Top Industry Leaders in the Cardiomyopathy Medication Market
Cytokinetics (US) Received FDA approval for aficamten (Myodist®), the first FDA-approved medication specifically for hypertrophic cardiomyopathy (HCM).Partnering with healthcare providers to educate clinicians and improve access to aficamten for patients with HCM.
Bristol Myers Squibb (US) Acquired Karuna Therapeutics and RayzeBio to strengthen their neuroscience and oncology portfolios, offering potential benefits for future cardiomyopathy-related drug development.Continued marketing Camzyos (Mavacamten), their FDA-approved medication for symptomatic HCM, focusing on expanding patient access and exploring its use in early-stage disease.
Novartis (Switzerland) Received breakthrough therapy designation for omecamtiv mecarbil (OMT) from the FDA for the treatment of heart failure with preserved ejection fraction (HFpEF).Conducting Phase III clinical trials for OMT, aiming to establish its efficacy and safety as a potential novel treatment option for HFpEF.
Tenaya Therapeutics (US) Initiated Phase IIb clinical trials for levosimendin, a potential treatment for HCM and HFpEF, to evaluate its effectiveness in improving cardiac function and symptoms.Collaborating with research institutions to investigate the underlying mechanisms of cardiomyopathy and identify new therapeutic targets.
American Heart Association (AHA) Updated their guidelines for the management of heart failure, emphasizing personalized treatment plans and including recommendations on novel medication options for specific cardiomyopathy types.Providing educational resources and patient support programs to raise awareness about cardiomyopathy and empower individuals to manage their condition effectively.
List of Cardiomyopathy Medication Key Companies in The Market
- Pfizer Inc.
- PhaseBio Pharmaceuticals, Inc.
- Array Biopharma, Inc.
- AstraZeneca
- Sanofi-Aventis US LLC
- Hoffmann-La Roche Ltd
- Merck & Co., Inc.
- Capricor Therapeutics
- MyoKardia
- Janssen Products, LP
- Ionis Pharmaceuticals, Inc.
- Medtronic
- Becton And Dickson & Co.
- Biomerieux
- Teva Pharmaceutical Industries Ltd